|
HY-103693-10mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-100mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-25mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-5mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-103693-50mg
|
MedChemexpress LLC
|
NAZ2329 [CAS 2809469-05-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10461-10mg
|
MedChemexpress LLC
|
PF-573228 [CAS 869288-64-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10461-100mg
|
MedChemexpress LLC
|
PF-573228 [CAS 869288-64-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10461-5mg
|
MedChemexpress LLC
|
PF-573228 [CAS 869288-64-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10461-50mg
|
MedChemexpress LLC
|
PF-573228 [CAS 869288-64-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-108829-1mg
|
MedChemexpress LLC
|
Abatacept [CAS 332348-12-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-108829-5mg
|
MedChemexpress LLC
|
Abatacept [CAS 332348-12-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111149A-10mg
|
MedChemexpress LLC
|
PS372424 (hydrochloride) [CAS 1596362-29-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111149A-5mg
|
MedChemexpress LLC
|
PS372424 (hydrochloride) [CAS 1596362-29-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-115531-10mg
|
MedChemexpress LLC
|
UNC-2170 [CAS 1648707-58-7]
|
|
Cancer-programmed cell death
|
|
|
HY-115531-100mg
|
MedChemexpress LLC
|
UNC-2170 [CAS 1648707-58-7]
|
|
Cancer-programmed cell death
|
|
|
HY-115531-25mg
|
MedChemexpress LLC
|
UNC-2170 [CAS 1648707-58-7]
|
|
Cancer-programmed cell death
|
|
|
HY-115531-5mg
|
MedChemexpress LLC
|
UNC-2170 [CAS 1648707-58-7]
|
|
Cancer-programmed cell death
|
|
|
HY-115531-50mg
|
MedChemexpress LLC
|
UNC-2170 [CAS 1648707-58-7]
|
|
Cancer-programmed cell death
|
|
|
HY-122587-10mg
|
MedChemexpress LLC
|
AVG-233 [CAS 2151937-80-1]
|
|
COVID-19-anti-virus
|
|
|
HY-122587-100mg
|
MedChemexpress LLC
|
AVG-233 [CAS 2151937-80-1]
|
|
COVID-19-anti-virus
|
|
|
HY-122587-25mg
|
MedChemexpress LLC
|
AVG-233 [CAS 2151937-80-1]
|
|
COVID-19-anti-virus
|
|
|
HY-122587-5mg
|
MedChemexpress LLC
|
AVG-233 [CAS 2151937-80-1]
|
|
COVID-19-anti-virus
|
|
|
HY-122587-50mg
|
MedChemexpress LLC
|
AVG-233 [CAS 2151937-80-1]
|
|
COVID-19-anti-virus
|
|
|
HY-125837-10mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
|
HY-125837-100mg
|
MedChemexpress LLC
|
MS31 [CAS 2366264-12-0]
|
|
Cancer-programmed cell death
|
|
